OneOme's RightMed® comprehensive test and supporting tools help providers make more personalized prescription decisions for their patients, which may result in more effective medications and fewer ...
OneOme's RightMed® comprehensive test and supporting tools help providers make more personalized prescription decisions for their patients, which may result in more effective medications and fewer side effects. The RightMed test is a pharmacogenomic test (also called a medication response test) that analyzes a person's DNA to predict how he or she is likely to respond to a medication. The test covers hundreds of medications used across psychiatry, oncology, pain management, cardiology, and many other areas. OneOme was co-developed and exclusively licensed from Mayo Clinic to bring pharmacogenomics into routine clinical care. OneOme is privately held, based in Minneapolis, MN, and backed by Invenshure, LLC and Mayo Clinic. For more information, visit www.oneome.com and follow us here for updates from OneOme.